Multiple mechanisms likely contribute to the improved efficacy of SGRP-secreting CAR T cells, and potential cooperation between SGRP, IFNγ, and CCL3-like chemoattractants might be crucial to eliminate bystander antigen-negative tumor cells (Fig. 9b). This evidence concerns the gene CCL3 and neoplasm.